<DOC>
	<DOCNO>NCT00861276</DOCNO>
	<brief_summary>Objective : To assess impact instructional guidance regular use use nicotine nasal spray ( NNS ) true use NNS first three week smoke cessation heavy smoker willing quit . Methods : This randomize , open , controlled trial include 50 patient heavy smoker , willing quit , attend academic outpatient clinic Western Switzerland . Patients randomised instruction NNS use `` ad libitum '' ( administration whenever craving appear ; control group ) use NNS least every hour awake ( intervention group ) . Intakes monitor use electronic device fix spray unit ( MDILogTM ) first three week use . Self report abstinence smoking six month confirm expired-air carbon monoxide . Using intention-to-treat analysis , random-effect GLS regression use calculate mean difference daily dose group control lack independence measure individual .</brief_summary>
	<brief_title>Nicotine Substitute Prescribed Hourly Intake ad Libitum Heavy Smokers Willing Quit</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Highly dependent smoker stage preparation accord Prochaska Di Clemente 's stage change model History myocardial infarction precede 3 month Pregnancy breastfeed Use form smokeless tobacco nicotine replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Smoking Cessation</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Administration dosage</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>